NorthWest Biotherapeutics Inc (NWBO)

[FeMike]

Here’s the fly in the ointment. Management has ostensibly restricted the information it provides to shareholders, well beyond what’s considered reasonable for a public company. And I might add, what’s necessary to make well informed investment decisions.

Absolutely correct.

There is no reason why the investor base, at a bare minimum, should not know what the company's plan is for regulatory approvals of their flagship product that wrapped P3 trials over two years ago. None.